Harmony Biosciences Holdings (HRMY) FCF Margin (QoQ) (2020 - 2026)

Harmony Biosciences Holdings (HRMY) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Harmony Biosciences Holdings 2.07 Bn 1.55 Bn 170.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,882.00
Dec 31, 2025 633.00
Sep 30, 2025 581.00
Jun 30, 2025 2,124.00
Mar 31, 2025 -1,896.00
Dec 31, 2024 -61.00
Sep 30, 2024 1,360.00
Jun 30, 2024 416.00
Mar 31, 2024 -2,532.00
Dec 31, 2023 609.00
Sep 30, 2023 1,176.00
Jun 30, 2023 -811.00
Mar 31, 2023 1,493.00
Dec 31, 2022 -2,624.00
Sep 30, 2022 1,555.00
Jun 30, 2022 -229.00
Mar 31, 2022 -738.00
Dec 31, 2021 358.00
Sep 30, 2021 1,336.00
Jun 30, 2021 322.00